Viking Therapeutics Inc. (VKTX)
Market Closed
16 Oct, 08:00 PM
$
25. 17
-2.2
-8.038%
$
3.48B Market Cap
- P/E Ratio
- Div Yield
7.56M Volume
-0.92 Eps
$ 27.37
Previous Close 
Want to track VKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Is Viking Therapeutics Stock a Buy?
Viking's GLP-1 inhibitor candidate has shown promise for weight loss in clinical trials. But investors should keep in mind that the company has no approved products yet.
Fool | 2 years ago
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
With innovation, millions of retiring baby boomers, demand for better care, patent cliffs, gene-editing, massive interest in weight-loss treatments, and an increase in mergers, biotech stocks to buy have a good deal of upside ahead. Look at weight loss stocks, like Viking Therapeutics (NASDAQ: VKTX ), for example.
Investorplace | 2 years ago
2026 © Marketlog. All Rights Reserved.
